xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1000229.xml | 1000229 | 2023-08-14-07:00 | 7684681 | 1,993 | Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. | European journal of immunology | H W Nijman; J G Houbiers; M P Vierboom; S H van der Burg; J W Drijfhout; J D'Amaro; P Kenemans; C J Melief; W M Kast | 22499 | GSSEQAAEA | FragmentOfANaturalSequenceMolecule | Peptide from protein | GSSEQAAEA | 9 | null | 194 | 202 | 11320 | P03485.1 | null | Exact Epitope | Not determined | MhcBinding | 1004722 | 185 | Table 1 | Negative | false | 0.97 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
1000229.xml | 1000229 | 2023-08-14-07:00 | 7684681 | 1,993 | Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. | European journal of immunology | H W Nijman; J G Houbiers; M P Vierboom; S H van der Burg; J W Drijfhout; J D'Amaro; P Kenemans; C J Melief; W M Kast | 11134 | EAMEVASQA | FragmentOfANaturalSequenceMolecule | Peptide from protein | EAMEVASQA | 9 | null | 201 | 209 | 11320 | P03485.1 | null | Exact Epitope | Not determined | MhcBinding | 1004723 | 185 | Table 1 | Negative | false | 0.98 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1000229.xml | 1000229 | 2023-08-14-07:00 | 7684681 | 1,993 | Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. | European journal of immunology | H W Nijman; J G Houbiers; M P Vierboom; S H van der Burg; J W Drijfhout; J D'Amaro; P Kenemans; C J Melief; W M Kast | 9163 | DLLENLQAY | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLLENLQAY | 9 | null | 232 | 240 | 11320 | P03485.1 | null | Exact Epitope | Not determined | MhcBinding | 1004724 | 185 | Table 1 | Negative | false | 0.99 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 12167 | HA123-138 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EGFTWTGVTQNGGSNA | 16 | null | 139 | 154 | 387139 | P03437.1 | null | Epitope containing region/antigenic site | Not determined | BCell | 1004378 | 316 | Table 2 | Negative | false | null | 10000067 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 12167 | HA123-138 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EGFTWTGVTQNGGSNA | 16 | null | 139 | 154 | 387139 | P03437.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1004369 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 12167 | HA123-138 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EGFTWTGVTQNGGSNA | 16 | null | 139 | 154 | 387139 | P03437.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1004375 | 69 | Table 3 | Negative | false | null | 10000051 | null | null | null | 183 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 12167 | HA123-138 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EGFTWTGVTQNGGSNA | 16 | null | 139 | 154 | 387139 | P03437.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1004365 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004556 | 316 | Table 2, Figure 2 | Negative | false | null | 10000067 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004560 | 34 | Figure 2 | Positive | true | null | 10000067 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004562 | 316 | Table 4, Figure 3 | Negative | false | null | 10000051 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004550 | 69 | Table 1 | Positive | true | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004554 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004549 | 69 | Table 1 | Positive | true | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004551 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004555 | 69 | Table 3 | Negative | false | null | 10000051 | null | null | null | 183 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73662 | 46F/HA126-134/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFTWTGVTQNGAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004553 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004573 | 316 | Table 4, Figure 3 | Negative | false | null | 10000051 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004571 | 316 | Table 2, Figure 2 | Positive | true | null | 10000067 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004568 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004566 | 69 | Table 1 | Positive | true | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004564 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004569 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004570 | 69 | Table 3 | Negative | false | null | 10000051 | null | null | null | 183 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73663 | 46F/HA127-133/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFWTGVTQNAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004565 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 3 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73659 | 46F/HA128-132/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSTGVTQKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004609 | 316 | Table 2 | Negative | false | null | 10000067 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 7 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73659 | 46F/HA128-132/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSTGVTQKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004610 | 34 | Figure 2 | Positive | true | null | 10000067 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 7 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73659 | 46F/HA128-132/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSTGVTQKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004606 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 7 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73659 | 46F/HA128-132/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSTGVTQKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004607 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 7 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73659 | 46F/HA128-132/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSTGVTQKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004602 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 7 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73659 | 46F/HA128-132/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSTGVTQKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004604 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 7 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73659 | 46F/HA128-132/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSTGVTQKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004608 | 69 | Table 3 | Positive | true | null | 10000051 | null | null | null | 183 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 7 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004620 | 34 | Figure 2 | Positive | true | null | 10000067 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004619 | 316 | Table 2, Figure 2 | Negative | false | null | 10000067 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004614 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004615 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004613 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004616 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004617 | 69 | Table 1 | Positive | true | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004618 | 69 | Table 3 | Positive | true | null | 10000051 | null | null | null | 183 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73661 | 46F/HA129-131/54A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSYGVTNKAKGIT | 16 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004612 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73660 | 46F/HA127-133/54A (18-mer) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSWTGVTQNKAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004629 | 316 | Table 2, Figures 2 and 3 | Positive | true | null | 10000067 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 5 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73660 | 46F/HA127-133/54A (18-mer) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSWTGVTQNKAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | BCell | 1004631 | 316 | Table 4, Figure 3 | Positive | true | null | 10000051 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 5 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73660 | 46F/HA127-133/54A (18-mer) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSWTGVTQNKAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004628 | 69 | Table 3 | Positive | true | null | 10000051 | null | null | null | 183 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73660 | 46F/HA127-133/54A (18-mer) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSWTGVTQNKAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004622 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73660 | 46F/HA127-133/54A (18-mer) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSWTGVTQNKAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004627 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73660 | 46F/HA127-133/54A (18-mer) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSWTGVTQNKAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004626 | 69 | Table 1 | Positive | true | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
1000235.xml | 1000235 | 2025-11-06-08:00 | 7526571 | 1,994 | Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. | Vaccine | H Naruse; K Ogasawara; K Takami; K Kajino; T Gotohda; Y Itoh; T Miyazaki; R A Good; K Onoè | 73660 | 46F/HA127-133/54A (18-mer) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YEGFSWTGVTQNKAKGIT | 18 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 1004624 | 69 | Table 1 | Negative | false | null | 10000067 | null | null | null | 181 | null | T cell | lymphoid | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77556 | J14 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D283 | null | null | 11553 | P68762.2 | D283 | Partial Epitope | Not determined | BCell | 1004739 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 8 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77558 | J9 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | K186, N187 | null | null | 11553 | P68762.2 | K186, N187 | Partial Epitope | Not determined | BCell | 1004740 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 3 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77561 | Q5 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N190, E245 | null | null | 11553 | P68762.2 | N190, E245 | Partial Epitope | Not determined | BCell | 1004742 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 8 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77562 | U9 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | S206, E245 | null | null | 11553 | P68762.2 | S206, E245 | Partial Epitope | Not determined | BCell | 1004743 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 9 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77557 | K16 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D367 | null | null | 11553 | P68762.2 | D367 | Partial Epitope | Not determined | BCell | 1004744 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 9 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77559 | U1 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | K212, F217 | null | null | 11553 | P68762.2 | K212, F217 | Partial Epitope | Not determined | BCell | 1004745 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 5 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77560 | U2 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | L178, E208, K212 | null | null | 11553 | P68762.2 | L178, E208, K212 | Partial Epitope | Not determined | BCell | 1004746 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 1 |
1000236.xml | 1000236 | 2023-12-29-08:00 | 1376542 | 1,992 | Location of neutralizing epitopes on the hemagglutinin-esterase protein of influenza C virus. | Virology | M Matsuzaki; K Sugawara; K Adachi; S Hongo; H Nishimura; F Kitame; K Nakamura | 77563 | D37 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | T226, V266 | null | null | 11553 | P68762.2 | T226, V266 | Partial Epitope | Not determined | BCell | 1004747 | 316 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 2 |
1000237.xml | 1000237 | 2023-08-18-07:00 | 7511212 | 1,994 | Analysis of antibody-antigen and antibody-anti-(idiotypic antibody) cross-reactivity using synthetic peptide probes. | Molecular immunology | T L McInerney; L E Brown; V R Sutton; D C Jackson | 46443 | HA 322-328 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NVPEKQT | 7 | null | 322 | 328 | 132504 | 2VIU_A | null | Exact Epitope | Not determined | BCell | 1004594 | 34 | Figure 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 9 |
1000237.xml | 1000237 | 2023-08-18-07:00 | 7511212 | 1,994 | Analysis of antibody-antigen and antibody-anti-(idiotypic antibody) cross-reactivity using synthetic peptide probes. | Molecular immunology | T L McInerney; L E Brown; V R Sutton; D C Jackson | 46443 | HA 322-328 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NVPEKQT | 7 | null | 322 | 328 | 132504 | 2VIU_A | null | Exact Epitope | Not determined | BCell | 1004591 | 34 | Figure 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 9 |
1000237.xml | 1000237 | 2023-08-18-07:00 | 7511212 | 1,994 | Analysis of antibody-antigen and antibody-anti-(idiotypic antibody) cross-reactivity using synthetic peptide probes. | Molecular immunology | T L McInerney; L E Brown; V R Sutton; D C Jackson | 46443 | HA 322-328 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NVPEKQT | 7 | null | 322 | 328 | 132504 | 2VIU_A | null | Exact Epitope | Not determined | BCell | 1004592 | 250 | Table 1 | Positive | true | 333.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 9 |
1000237.xml | 1000237 | 2023-08-18-07:00 | 7511212 | 1,994 | Analysis of antibody-antigen and antibody-anti-(idiotypic antibody) cross-reactivity using synthetic peptide probes. | Molecular immunology | T L McInerney; L E Brown; V R Sutton; D C Jackson | 46443 | HA 322-328 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NVPEKQT | 7 | null | 322 | 328 | 132504 | 2VIU_A | null | Exact Epitope | Not determined | BCell | 1004597 | 311 | Figure 4 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 9 |
1000238.xml | 1000238 | 2025-12-11-08:00 | 1546293 | 1,992 | Structural evidence for induced fit as a mechanism for antibody-antigen recognition. | Science (New York, N.Y.) | J M Rini; U Schulze-Gahmen; I A Wilson | 73601 | influenza virus X47 HA1 peptide (100-107) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YDVPDYAS | 8 | null | 117 | 124 | 392809 | P03435 | null | Exact Epitope | Representative selection | BCell | 1004385 | 436 | Figures 1, 3, 5, Tables 1, 2 and PDB 1HIM | Positive | true | 2.9 | 10000248 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 5 |
1000240.xml | 1000240 | 2023-08-18-07:00 | 11979050 | 2,002 | A candidate vaccine against influenza virus intensively improved the immunogenicity of a neutralizing epitope. | International archives of allergy and immunology | Yun Lu; Jian Ding; Wanli Liu; Ying-Hua Chen | 30036 | F3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KAYSNCYPYDVPDY | 14 | null | 92 | 105 | 63106 | O40714.1 | null | Epitope containing region/antigenic site | Not determined | BCell | 1004875 | 316 | Figure 4 | Positive | true | null | 10000206 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 9 |
1000240.xml | 1000240 | 2023-08-18-07:00 | 11979050 | 2,002 | A candidate vaccine against influenza virus intensively improved the immunogenicity of a neutralizing epitope. | International archives of allergy and immunology | Yun Lu; Jian Ding; Wanli Liu; Ying-Hua Chen | 30036 | F3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KAYSNCYPYDVPDY | 14 | null | 92 | 105 | 63106 | O40714.1 | null | Epitope containing region/antigenic site | Not determined | BCell | 1004872 | 34 | Figure 1 | Negative | false | null | 9606 | null | null | DOID:8469 | null | null | null | null | null | Exact match to reference information | Not determined | null | 9 |
1000240.xml | 1000240 | 2023-08-18-07:00 | 11979050 | 2,002 | A candidate vaccine against influenza virus intensively improved the immunogenicity of a neutralizing epitope. | International archives of allergy and immunology | Yun Lu; Jian Ding; Wanli Liu; Ying-Hua Chen | 30036 | F3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KAYSNCYPYDVPDY | 14 | null | 92 | 105 | 63106 | O40714.1 | null | Epitope containing region/antigenic site | Not determined | BCell | 1004873 | 34 | Figure 2 | Positive | true | null | 10000206 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 9 |
1000240.xml | 1000240 | 2023-08-18-07:00 | 11979050 | 2,002 | A candidate vaccine against influenza virus intensively improved the immunogenicity of a neutralizing epitope. | International archives of allergy and immunology | Yun Lu; Jian Ding; Wanli Liu; Ying-Hua Chen | 30036 | F3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KAYSNCYPYDVPDY | 14 | null | 92 | 105 | 63106 | O40714.1 | null | Epitope containing region/antigenic site | Not determined | BCell | 1004874 | 37 | Figure 3 | Positive | true | null | 10000206 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 9 |
1000242.xml | 1000242 | 2026-02-03-08:00 | 7527838 | 1,994 | Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. | The Journal of general virology | R Lambkin; L McLain; S E Jones; S L Aldridge; N J Dimmock | 77027 | Site A | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | G144 | null | null | 392810 | 0704243A | G144 | Partial Epitope | Representative selection | BCell | 1004902 | 316 | Table 2 | Positive | true | null | 10000000 | null | 8 weeks | null | null | null | null | null | null | Not determined | Representative selection | null | 7 |
1000242.xml | 1000242 | 2026-02-03-08:00 | 7527838 | 1,994 | Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. | The Journal of general virology | R Lambkin; L McLain; S E Jones; S L Aldridge; N J Dimmock | 77027 | Site A | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | G144 | null | null | 392810 | 0704243A | G144 | Partial Epitope | Representative selection | BCell | 1004907 | 231 | Table 2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Not determined | null | null | 7 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1005188 | 67 | Figure 1, tables 1 and 2 | Positive | true | null | 10000067 | null | null | null | 172 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 9 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1005190 | 67 | Figure 1 | Positive | true | null | 10000067 | null | null | null | 172 | null | T cell | spleen | Cell Line / Clone | Not determined | Exact match to reference information | null | 9 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 211044 | null | null | Exact Epitope | Not determined | MhcBinding | 1005382 | 185 | Figure 1 and table 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 15248 | NP 324-332 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FAPGNYPAL | 9 | null | 324 | 332 | 3052731 | P04857.1 | null | Exact Epitope | Not determined | TCell | 1005189 | 67 | Figure 1 and table 1 | Positive | true | null | 10000067 | null | null | null | 122 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 9 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 15248 | NP 324-332 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FAPGNYPAL | 9 | null | 324 | 332 | 3052731 | P04857.1 | null | Exact Epitope | Not determined | TCell | 1005191 | 67 | Figure 1 | Positive | true | null | 10000067 | null | null | null | 122 | null | T cell | spleen | Cell Line / Clone | Not determined | Exact match to reference information | null | 9 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 15248 | NP 324-332 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FAPGNYPAL | 9 | null | 324 | 332 | 3052731 | P04857.1 | null | Exact Epitope | Not determined | MhcBinding | 1005383 | 185 | Figure 1 and table 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 55289 | NP 118-126 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RPQASGVYM | 9 | null | 118 | 126 | 3052303 | P07400.1 | null | Exact Epitope | Not determined | TCell | 1005192 | 67 | Figure 1 and table 1 | Positive | true | null | 10000000 | null | null | null | 126 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 7 |
1000243.xml | 1000243 | 2025-11-06-08:00 | 1446701 | 1,992 | In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. | European journal of immunology | X Zhou; U M Abdel Motal; L Berg; M Jondal | 55289 | NP 118-126 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RPQASGVYM | 9 | null | 118 | 126 | 3052303 | P07400.1 | null | Exact Epitope | Not determined | MhcBinding | 1005385 | 185 | Figure 1 and table 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1000244.xml | 1000244 | 2025-11-06-08:00 | 2462610 | 1,989 | Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen. | The Journal of experimental medicine | G Chimini; P Pala; J Sire; B R Jordan; J L Maryanski | 56578 | HLA CW3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RYLKNGKETLQRA | 13 | null | 169 | 181 | 9606 | CAA06438.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1031727 | 67 | Figure 3 | Positive | true | null | 10090 | null | null | null | 124 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | null | null | 3 |
1000244.xml | 1000244 | 2025-11-06-08:00 | 2462610 | 1,989 | Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen. | The Journal of experimental medicine | G Chimini; P Pala; J Sire; B R Jordan; J L Maryanski | 56571 | HLA A24 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RYLENGKETLQRA | 13 | null | 194 | 206 | 9606 | AML03226.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1031732 | 67 | Figure 3 | Positive | true | null | 10090 | null | null | null | 124 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | null | null | 3 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 13263 | ELRSRYWAI | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1004563 | 67 | Figure 2 | Positive | true | null | 9606 | null | null | null | 301 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | null | null | 8 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 13263 | ELRSRYWAI | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1004557 | 67 | Figure 1A | Positive | true | null | 9606 | null | null | null | 301 | null | T cell | blood | Short Term Restimulated | Not determined | Not determined | null | 8 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 13263 | ELRSRYWAI | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1004561 | 67 | Figure 1B | Positive | true | null | 9606 | null | null | null | 301 | null | T cell | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 8 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 13263 | ELRSRYWAI | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1004558 | 67 | Figure 1A | Positive | true | null | 9606 | null | null | null | 301 | null | T cell | blood | Short Term Restimulated | Internal Identifier-no external match available | Not determined | null | 8 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 13263 | ELRSRYWAI | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1004559 | 67 | Figure 1B | Positive | true | null | 9606 | null | null | null | 301 | null | T cell | blood | Short Term Restimulated | Not determined | Not determined | null | 8 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 46935 | PARSLREWEL | FragmentOfANaturalSequenceMolecule | Peptide from protein | PARSLREWEL | 10 | null | null | null | 10376 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 1004576 | 67 | Figure 1B | Negative | false | null | 9606 | null | null | null | 301 | null | T cell | blood | Short Term Restimulated | Not determined | Not determined | null | 6 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 52260 | QRRYRRIYPL | FragmentOfANaturalSequenceMolecule | Peptide from protein | QRRYRRIYPL | 10 | null | null | null | 10376 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 1004579 | 67 | Figure 1B | Negative | false | null | 9606 | null | null | null | 301 | null | T cell | blood | Short Term Restimulated | Not determined | Not determined | null | 5 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 762 | ADRPRAWRL | FragmentOfANaturalSequenceMolecule | Peptide from protein | ADRPRAWRL | 9 | null | 74 | 82 | 10376 | CAD53394.1 | null | Exact Epitope | Not determined | TCell | 1004580 | 67 | Figure 1B | Negative | false | null | 9606 | null | null | null | 301 | null | T cell | blood | Short Term Restimulated | Not determined | Not determined | null | 7 |
1000245.xml | 1000245 | 2025-11-06-08:00 | 7685314 | 1,993 | Prediction of an HLA B8-restricted influenza epitope by motif. | Immunology | A Suhrbier; C Schmidt; A Fernan | 16878 | FLRGRAYGL | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLRGRAYGL | 9 | null | 11 | 19 | 10376 | AAB20988.1 | null | Exact Epitope | Not determined | TCell | 1004588 | 67 | Figure 1B | Positive | true | null | 9606 | null | null | null | 301 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 9 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59820 | NP 367-373 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMDA | 7 | null | 367 | 373 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004782 | 274 | Table 1 | Positive | true | 2040.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59820 | NP 367-373 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMDA | 7 | null | 367 | 373 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004860 | 276 | Table 1 | Positive | true | 0.0000057 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59824 | NP 367-374 (A/Puerto Rico/8/1934(H1N1)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMETM | 8 | null | 367 | 374 | 211044 | P03466.2 | null | Exact Epitope | Representative selection | MhcBinding | 1004785 | 274 | Table 1 and Figure 2a, Figures 1c and 1d | Positive | true | 33000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59824 | NP 367-374 (A/Puerto Rico/8/1934(H1N1)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMETM | 8 | null | 367 | 374 | 211044 | P03466.2 | null | Exact Epitope | Representative selection | MhcBinding | 1004862 | 276 | Table 1 | Positive | true | 0.00000035 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59822 | NP 367-375 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMDAME | 9 | null | 367 | 375 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004863 | 276 | Table 1 | Positive | true | 0.000083 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59822 | NP 367-375 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMDAME | 9 | null | 367 | 375 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004786 | 274 | Table 1, Figures 2b and 2c | Positive | true | 138.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59823 | NP 367-379 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMDAMESSTL | 13 | null | 367 | 379 | 384505 | P03467.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1004787 | 274 | Table 1 and Figure 2b | Positive | true | 152.4 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 59823 | NP 367-379 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENMDAMESSTL | 13 | null | 367 | 379 | 384505 | P03467.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1004864 | 276 | Table 1 | Positive | true | 0.000076 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 4578 | NP 366-374 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMDAM | 9 | null | 366 | 374 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004867 | 276 | Table 1 | Positive | true | 0.0000091 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 4578 | NP 366-374 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMDAM | 9 | null | 366 | 374 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004791 | 274 | Table 1 | Positive | true | 1260.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 25433 | NP 365-374 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IASNENMDAM | 10 | null | 365 | 374 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004868 | 276 | Table 1 | Positive | true | 0.000019 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1000247.xml | 1000247 | 2024-02-29-08:00 | 1889458 | 1,991 | The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. | European journal of immunology | V Cerundolo; T Elliott; J Elvin; J Bastin; H G Rammensee; A Townsend | 25433 | NP 365-374 (A/nt/60/1968(H3N2)) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IASNENMDAM | 10 | null | 365 | 374 | 384505 | P03467.1 | null | Exact Epitope | Representative selection | MhcBinding | 1004792 | 274 | Table 1 and Figure 2b | Positive | true | 606.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
1000248.xml | 1000248 | 2025-11-06-08:00 | 9593011 | 1,998 | Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes. | The Journal of infectious diseases | S Sambhara; S Woods; R Arpino; A Kurichh; A Tamane; B Underdown; M Klein; K Lövgren Bengtsson; B Morein; D Burt | 67440 | (NP) 147-158 (R-) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | TYQRTRALVTG | 11 | null | null | null | null | null | null | Exact Epitope | null | TCell | 1005913 | 67 | Table 1 | Positive | true | null | 10000000 | F | 6-8 weeks | null | 124 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Not determined | null | 3 |
1000248.xml | 1000248 | 2025-11-06-08:00 | 9593011 | 1,998 | Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes. | The Journal of infectious diseases | S Sambhara; S Woods; R Arpino; A Kurichh; A Tamane; B Underdown; M Klein; K Lövgren Bengtsson; B Morein; D Burt | 29691 | HA2 189-199 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IYSTVASSLVL | 11 | null | 533 | 543 | 11320 | ABF71860.1 | null | Exact Epitope | Representative selection | TCell | 1005916 | 67 | Table 1, Table 1, Table 1, Figure 3 | Positive | true | null | 10000000 | F | 6-8 weeks | null | 124 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Not determined | null | 9 |
1000250.xml | 1000250 | 2025-11-06-08:00 | 3491326 | 1,986 | H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. | Nature | J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini | 74750 | CW3 171-186 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLKNGKETLQRAEHPK | 16 | null | 195 | 210 | 9606 | P04222.2 | null | Epitope containing region/antigenic site | Not determined | TCell | 1031744 | 67 | Figures 2 and 3 | Positive | true | null | 10000055 | null | null | null | 124 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Not determined | null | 5 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.